Loading clinical trials...
Loading clinical trials...
Leveraging EEG for Antidepressant Prediction With Sertraline and Escitalopram (LEAP-SE): A Multicenter, Randomized, Blinded Outcome Study of EEG-guided Treatment With Sertraline Versus Escitalopram in Adults With Major Depressive Disorder
Conditions
Interventions
Sertraline
Escitalopram
Start Date
October 15, 2020
Primary Completion Date
May 30, 2023
Completion Date
May 30, 2023
Last Updated
October 19, 2020
NCT07115329
NCT06793397
NCT07025720
NCT06780917
NCT04480918
NCT06878859
Lead Sponsor
Alto Neuroscience
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions